The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.

Former club captain Barry Roche leaves Morecambe after 17 years at the Shrimps that spanned both playing and coaching roles.

Alainy Chiloh Roché is ready to tee up for a career in medicine or real estate development, but she will continue to improve ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...

Venclexta, when combined with azacitidine, elicited an overall survival benefit below 10% in patients with myelodysplastic ...

Roche and Prothena are forging ahead to late-stage studies for their investigational Parkinson’s disease antibody ...

Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

Prothena Corporation plc (NASDAQ:PRTA) is an Ireland-based late-stage clinical biotechnology company that identifies and ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

Roche entered into a Licensing, Development, and Commercialisation agreement with Prothena in December 2013 to develop and ...

Roche and AbbVie have once again come up short in their attempt to gain an additional indication for their blockbuster blood ...

Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational ...